These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27856466)

  • 1. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511-533.
    Blood; 2016 Nov; 128(20):2373. PubMed ID: 27856466
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
    Holter-Chakrabarty JL; Pierson N; Zhang MJ; Zhu X; Akpek G; Aljurf MD; Artz AS; Baron F; Bredeson CN; Dvorak CC; Epstein RB; Lazarus HM; Olsson RF; Selby GB; Williams KM; Cooke KR; Pasquini MC; McCarthy PL
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1251-7. PubMed ID: 25840335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
    Naparstek E; Or R; Nagler A; Cividalli G; Engelhard D; Aker M; Gimon Z; Manny N; Sacks T; Tochner Z
    Br J Haematol; 1995 Mar; 89(3):506-15. PubMed ID: 7734348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
    Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
    J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M; Pession A; Messina C; Bonetti F; Favre C; Prete A; Cesaro S; Porta F; Mazzarino I; Giorgiani G; Rondelli R; Locatelli F
    J Clin Oncol; 1999 Jun; 17(6):1838-46. PubMed ID: 10561223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.
    Tucunduva L; Volt F; Cunha R; Locatelli F; Zecca M; Yesilipek A; Caniglia M; Güngör T; Aksoylar S; Fagioli F; Bertrand Y; Addari MC; de la Fuente J; Winiarski J; Biondi A; Sengeloev H; Badell I; Mellgren K; de Heredia CD; Sedlacek P; Vora A; Rocha V; Ruggeri A; Gluckman E;
    Br J Haematol; 2015 Apr; 169(1):103-10. PubMed ID: 25521756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Eder S; Labopin M; Arcese W; Or R; Majolino I; Bacigalupo A; de Rosa G; Volin L; Beelen D; Veelken H; Schaap NP; Kuball J; Cornelissen J; Nagler A; Mohty M;
    Eur J Haematol; 2016 Jan; 96(1):90-7. PubMed ID: 25807864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of leukaemic marrow and prevention of leukaemia relapse with total body irradiation and bone marrow transplantation.
    Frassoni F
    Med Oncol Tumor Pharmacother; 1991; 8(3):189-201. PubMed ID: 1803180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.
    Belkacémi Y; Pène F; Touboul E; Rio B; Leblond V; Gorin NC; Laugier A; Gemici C; Housset M; Ozsahin M
    Strahlenther Onkol; 1998 Feb; 174(2):92-104. PubMed ID: 9487372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients.
    Donato V; Iacari V; Zurlo A; Capua A; Tombolini V; Banelli E; Enrici RM; De Felice C; Giacco G; Iori AP; Arcese W; Biagini C
    Radiother Oncol; 1998 Sep; 48(3):267-76. PubMed ID: 9925246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
    Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW; Tutschka PJ; Brookmeyer R; Saral R; Beschorner WE; Bias WB; Braine HG; Burns WH; Elfenbein GJ; Kaizer H
    N Engl J Med; 1983 Dec; 309(22):1347-53. PubMed ID: 6355849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
    Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in acute nonlymphoblastic leukemia.
    Zwaan FE; Jansen J
    Semin Hematol; 1984 Jan; 21(1):36-42. PubMed ID: 6367055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.